Advertisement

Neurophysiology

, Volume 50, Issue 2, pp 108–115 | Cite as

Neurotoxicity of Cuprizone in Female and Male Rats: Electrophysiological Observations

  • C. Ünsal
  • M. ÖzcanEmail author
Article
  • 53 Downloads

Cuprizone induces massive demyelination in the CNS; however, the effects of cuprizone on the functions of the peripheral nervous system, as well as differential effects it may exert on males and females, have not yet been studied. Thus, we aimed to examine changes in the electromyographic characteristics of female and male Sprague-Dawley rats with cuprizone-induced demyelination. The body mass, food intake, nerve conduction velocity (NCV) along the sciatic nerve, latency, amplitude, and integral intensity (area) of the compound muscle action potential (CMAP; m. gastrocnemius) were measured weekly throughout a 4-week demyelination period, and histological sections of the brain and sciatic nerve were examined. Cuprizone led to a reduction in the NCV, CMAP amplitude and area, body mass, and food intake; simultaneously, it led to an increase in the CMAP latency. Notably, electrophysiological observations reveal that cuprizone affects both female and male rats, but males are more sensitive. This is the first study showing gender differences for the peripheral neurotoxicity of cuprizone.

Keywords

cuprizone rats multiple sclerosis demyelination nerve conduction velocity latency EMG 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. Kaji, A. Suzumura, and A. J. Sumner, “Physiological consequences of antiserum-mediated experimental demyelination in cns,” Brain, 111, Part 3, 675-694 (1988).CrossRefPubMedGoogle Scholar
  2. 2.
    T. Brismar, “Electrical properties of isolated demyelinated rat nerve fibres,” Acta Physiol. Scand., 113, No. 2, 161-166 (1981).CrossRefPubMedGoogle Scholar
  3. 3.
    J. A. Black, P. Felts, K. J. Smith, et al., “Distribution of sodium channels in chronically demyelinated spinal cord axons: Immuno-ultrastructural localization and electrophysiological observations,” Brain Res., 544, No. 1, 59-70 (1991).CrossRefPubMedGoogle Scholar
  4. 4.
    P. A. Felts, T. A. Baker, and K. J. Smith, “Conduction in segmentally demyelinated mammalian central axons,” J. Neurosci., 17, No. 19, 7267-7277 (1997).CrossRefPubMedGoogle Scholar
  5. 5.
    I. C. Maxwell and P. M. Le Quesne, “Conduction velocity in hexachlorophane neuropathy: Correlation between electrophysiological and histological findings,” J. Neurol. Sci., 43, No. 1, 95-110 (1979).CrossRefPubMedGoogle Scholar
  6. 6.
    M. Pollock, C. Calder, and S. Allpress, “Peripheral nerve abnormality in multiple sclerosis,” Ann. Neurol., 2, No. 1, 41-48 (1977).CrossRefPubMedGoogle Scholar
  7. 7.
    M. Rubin, G. Karpati, and S. Carpenter, “Combined central and peripheral myelinopathy,” Neurology, 37, No. 8, 1287-1290 (1987).CrossRefPubMedGoogle Scholar
  8. 8.
    I. Sarova-Pinhas, A. Achiron, R. Gilad, and Y. Lampl, “Peripheral neuropathy in multiple sclerosis: A clinical and electrophysiologic study,” Acta Neurol. Scand., 91, No. 4, 234-238 (1995).CrossRefPubMedGoogle Scholar
  9. 9.
    W. F. Blakemore, “Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone,” J. Neurol. Sci., 20, No. 1, 63-72 (1973).CrossRefPubMedGoogle Scholar
  10. 10.
    W. W. Carlton, “Spongiform encephalopathy induced in rats and guinea pigs by cuprizone,” Exp. Mol. Pathol., 10, No. 3, 274-287 (1969).CrossRefPubMedGoogle Scholar
  11. 11.
    M. M. Hiremath, Y. Saito, G. W. Knapp, et al., “Microglial/macrophage accumulation during cuprizone-induced demyelination in c57bl/6 mice,” J. Neuroimmunol., 92, Nos. 1/2, 38-49 (1998).Google Scholar
  12. 12.
    S. Love, “Cuprizone neurotoxicity in the rat: Morphologic observations,” J. Neurol. Sci., 84, Nos. 2/3, 223-237 (1988).CrossRefPubMedGoogle Scholar
  13. 13.
    S. K. Ludwin, “Central nervous system demyelination and remyelination in the mouse: An ultrastructural study of cuprizone toxicity,” Lab. Invest., 39, No. 6, 597-612 (1978).PubMedGoogle Scholar
  14. 14.
    G. K. Matsushima and P. Morell, “The neurotoxicant cuprizone as a model to study demyelination and remyelination in the central nervous system,” Brain Pathol., 11, No. 1, 107-116 (2001).CrossRefPubMedGoogle Scholar
  15. 15.
    J. L. Mason, J. J. Jones, M. Taniike, et al., “Mature oligodendrocyte apoptosis precedes igf-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination,” J. Neurosci. Res., 61, No. 3, 251-262 (2000).CrossRefPubMedGoogle Scholar
  16. 16.
    P. Morell, C. V. Barrett, J. L. Mason, et al., “Gene expression in brain during cuprizone-induced demyelination and remyelination,” Mol. Cell Neurosci., 12, Nos. 4/5, 220-227 (1998).CrossRefPubMedGoogle Scholar
  17. 17.
    A. M. Adamo, P. M. Paez, O. E. Escobar Cabrera, et al., “Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin,” Exp. Neurol., 198, No. 2, 519-529 (2006).CrossRefPubMedGoogle Scholar
  18. 18.
    K. Suzuki and Y. Kikkawa, “Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone),” Am. J. Pathol., 54, No. 2, 307-325 (1969).PubMedPubMedCentralGoogle Scholar
  19. 19.
    A. Hoke, “Animal models of peripheral neuropathies,” Neurotherapeutics, 9, No. 2, 262-269 (2012).CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    H. Lassmann, “Axonal injury in multiple sclerosis,” J. Neurol. Neurosurg. Psychiat., 74, No. 6, 695-697 (2003).CrossRefPubMedGoogle Scholar
  21. 21.
    R. Pogorzelski, E. Baniukiewicz, and W. Drozdowski, “Subclinical lesions of peripheral nervous system in multiple sclerosis patients,” Neurol. Neurochir. Pol., 38, No. 4, 257-264 (2004).PubMedGoogle Scholar
  22. 22.
    Y. Dake and T. Amemiya, “Electron microscopic study of the optic nerve in copper deficient rats,” Exp. Eye Res., 52, No. 3, 277-281 (1991).CrossRefPubMedGoogle Scholar
  23. 23.
    S. G. Waxman, “Conduction in myelinated, unmyelinated, and demyelinated fibers,” Arch. Neurol., 34, No. 10, 585-589 (1977).CrossRefPubMedGoogle Scholar
  24. 24.
    S. Herskovitz, S. N. Scelsa, and H. H. Schaumburg, Peripheral Neuropathies in Clinical Practice, Oxford University Press, New York, (2010).Google Scholar
  25. 25.
    B. Johnsen and A. Fuglsang-Frederiksen, “Electrodiagnosis of polyneuropathy,” Neurophysiol. Clin., 30, No. 6, 339-351 (2000).CrossRefPubMedGoogle Scholar
  26. 26.
    L. C. Taylor, W. Gilmore, and G. K. Matsushima, “Sjl mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination,” Brain Pathol., 19, No. 3, 467-479 (2009).CrossRefPubMedGoogle Scholar
  27. 27.
    L. C. Taylor, W. Gilmore, J. P. Ting, and G. K. Matsushima, “Cuprizone induces similar demyelination in male and female c57bl/6 mice and results in disruption of the estrous cycle,” J. Neurosci. Res., 88, No. 2, 391-402 (2010).CrossRefPubMedGoogle Scholar
  28. 28.
    P. Acs, M. Kipp, A. Norkute, et al., “17 beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice,” Glia, 57, No. 8, 807-814 (2009).CrossRefPubMedGoogle Scholar
  29. 29.
    L. C. Taylor, K. Puranam, W. Gilmore, et al., “17 betaestradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss,” Neurobiol. Dis., 39, No. 2, 127-137 (2010).CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    H. F. Harbo, R. Gold, and M. Tintore, “Sex and gender issues in multiple sclerosis,” Ther. Adv. Neurol. Disord., 6, No. 4, 237-248 (2013).CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    B. Katirji, “Clinical neurophysiology – clinical electromyography,” in: Bradley’s Neurology in Clinical Practice, Chapter 32B, R. B. Daroff, G. M. Fenichel, J. Jankovic, and J. C. Mazziotta (eds.), Elsevier, China (2012), pp. 394-420.CrossRefGoogle Scholar
  32. 32.
    J. Kimura, Electrodiagnosis in Diseases of Nerve and Muscle, Oxford University Press, New York (2013). CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Physiology, Faculty of Veterinary MedicineAdnan Menderes UniversityAydinTurkey
  2. 2.Department of Physiology, Faculty of Veterinary MedicineIstanbul UniversityİstanbulTurkey

Personalised recommendations